Provider FAQ’s
The ADIPOSET System is the backbone of our three products: Regenerys mL, Regenerys XL, and Lipostor. The Regenerys mL is used for smaller volume applications such as the face or hands whereas the Regenerys XL is for larger volume applications like the breast, buttocks, chest, etc.. We designed Lipostor for people who want to bank their fat for longer-term storage. Typical uses of Lipostor are to bank a patient’s younger fat for use when they are older or to hold stem cells for the possibility of a change in policy on the usage of autologous stem cells.
Additionally, the system enhances fat viability and longevity through sterile, closed-loop processing that reduces the risk of contamination. It optimizes processing and preservation techniques to ensure standardized, high-quality fat grafts with preserved regenerative potential.
The system’s fat banking capabilities facilitate staged procedures without the need for repeated harvesting, making it a cost-effective and efficient solution for long-term treatment planning.
Each sample is comprehensively tested upon delivery to our facility, providing valuable feedback and insights that allow for fine-tuning variables in the harvest technique. This process ensures a consistent and optimized approach to fat grafting, helping to improve procedural efficiency and ultimately leading to better patient outcomes.
Studies have shown that adipose tissue can retain significant cell viability over extended periods with proper cryopreservation techniques. Research indicates that certain cryopreservation methods can effectively preserve the functionality and viability of fat cells and regenerative cells within adipose tissue.providing valuable feedback and insights that allow for fine-tuning variables in the harvest technique. This process ensures a consistent and optimized approach to fat grafting, helping to improve procedural efficiency and ultimately leading to better patient outcomes.
It’s important to note that intrinsic factors such as the patient’s age, body mass index, and health status can influence the viability of harvested adipose-derived stem cells (ADSCs). Specimens received with less than 65% initial viability are not acceptable for cryopreservation.
The ADIPOSET® System by Tissue & Cell Technologies is currently designed to comply with regulatory requirements in the regions where it is offered. In the United States, the system is subject to FDA regulations, and its use falls within the scope of autologous human tissue applications that meet FDA guidelines for minimal manipulation.
Tissue & Cell Technologies has been developing the ADIPOSET® fat banking solution for over a decade. Over 1,200 patients have been safely and successfully treated with the ADIPOSET System in Europe, demonstrating its growing adoption and effectiveness in the field of regenerative medicine. This extensive global experience underscores the system’s reliability and potential for broader application as technology and regulations continue to evolve.
However, we are actively investigating these capabilities for the future in our European division, where regulatory frameworks offer a more progressive environment for advanced stem cell therapies. This strategic initiative allows us to stay at the forefront of regenerative medicine and prepare for potential regulatory changes in the U.S. as the landscape evolves. We would be happy to provide further information if you have any questions about our ongoing efforts and compliance.
One of the most exciting advancements in fat banking is the ability to preserve youthful cells in a state of suspended animation for future therapeutic applications. Adipose tissue is a rich reservoir of adipose-derived stem cells (ADSCs) and mesenchymal stem cells (MSCs), making it an invaluable resource as advancements in technology and evolving regulatory frameworks continue to expand the potential of regenerative medicine. The ability to utilize a patient’s younger cells later in life holds significant promise for enhanced regenerative treatments and personalized medical interventions. This approach not only leverages the biological advantages of youthful tissue but also presents the potential to treat serious diseases with cells that predate the onset of illness, offering a proactive approach to long-term health and wellness.
If you have further questions or need assistance, please contact us at info@tissueandcell.tech.
